Durable Capital Partners LP Sells 932,242 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Durable Capital Partners LP lowered its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 8.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,508,826 shares of the company's stock after selling 932,242 shares during the quarter. Durable Capital Partners LP owned approximately 2.49% of LifeStance Health Group worth $70,080,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Jennison Associates LLC raised its stake in LifeStance Health Group by 278.4% in the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock valued at $59,597,000 after acquiring an additional 5,949,438 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock valued at $25,977,000 after purchasing an additional 1,643,390 shares during the last quarter. Vanguard Group Inc. raised its position in shares of LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock valued at $78,781,000 after purchasing an additional 784,818 shares during the period. First Trust Advisors LP acquired a new stake in shares of LifeStance Health Group during the 4th quarter worth about $4,535,000. Finally, First Eagle Investment Management LLC boosted its holdings in shares of LifeStance Health Group by 182.8% during the 4th quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company's stock worth $5,790,000 after buying an additional 507,826 shares during the period. Institutional investors own 85.50% of the company's stock.

Analysts Set New Price Targets

Several research firms recently issued reports on LFST. Canaccord Genuity Group initiated coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price target for the company. KeyCorp began coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target on the stock. Finally, William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, LifeStance Health Group currently has an average rating of "Moderate Buy" and an average price target of $8.30.

LifeStance Health Group Stock Down 1.1 %

Shares of LFST opened at $6.55 on Wednesday. The company has a market capitalization of $2.55 billion, a PE ratio of -25.19 and a beta of 1.30. The stock's 50-day moving average price is $6.84 and its two-hundred day moving average price is $7.28. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $8.61.

Insider Buying and Selling

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now owns 339,810 shares of the company's stock, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 6.60% of the stock is owned by insiders.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.